               SEQUENCE LISTING

<110> Universiteit Hasselt

<120> Method and means for diagnosis of spondyloarthritis

<130> UHA-010

<150> EP19198081.2
<151> 2019-09-18

<160> 12

<170> BiSSAP 1.3.6

<210> 1
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.1

<400> 1
Ile Pro Gly Pro Ala Glu His Leu Gln His Gln 
1               5                   10      

<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.2

<400> 2
Trp Ala Pro Thr Ser Lys Thr Lys Asp Arg 
1               5                   10  

<210> 3
<211> 46
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.3

<400> 3
Trp Gly Gln Ala Glu Leu Met Asn Lys Asn Gly Val Gly Gln Lys Ile 
1               5                   10                  15      
Leu His Pro Leu Gly Leu Pro Asn His Leu His Arg Ser Phe Cys Pro 
            20                  25                  30          
Trp Leu Gly Leu Asp Phe Ile Arg Ser Phe Phe Trp Gly Arg 
        35                  40                  45      

<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.4

<400> 4
Ile Pro Glu Leu Leu Leu Trp Lys Ile Gln Pro 
1               5                   10      

<210> 5
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.5

<400> 5
Ile Pro Ile Ser Thr Phe 
1               5       

<210> 6
<211> 18
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.6

<400> 6
Ile Arg Gln Arg Cys Ser Pro Pro Gln Leu Gln His Leu Gly Pro Glu 
1               5                   10                  15      
Gln Cys 
        

<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.7

<400> 7
Trp Ala Glu Ser Tyr Phe Pro His Gln 
1               5                   

<210> 8
<211> 252
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.8

<400> 8
Ile Pro Pro Gly Glu Leu Glu Ala Leu Glu Gly Ala Thr Ser Leu Glu 
1               5                   10                  15      
Ala Pro Leu Ser Glu Glu Glu Tyr Arg Ala Leu Leu Glu Glu Leu Gln 
            20                  25                  30          
Asp Ala Arg Leu Gly Arg Gly Arg Leu Arg Ala Gly Arg Trp Pro Leu 
        35                  40                  45              
Phe Arg Arg Glu His Leu Ala Gly Tyr Val Gly Ser Cys Leu Pro His 
    50                  55                  60                  
Ala Thr Ser Thr Gly Leu Thr Ser Leu Gly Phe Leu Pro Ser Arg Ser 
65                  70                  75                  80  
Arg Pro Gly Glu Arg Leu His Thr Ala Glu Thr Pro His Ser Gly Glu 
                85                  90                  95      
Leu Pro Phe Phe Pro Gly His Pro Gly Ala Ser Arg Leu Gly Gln Arg 
            100                 105                 110         
Pro Asp Ala Leu His Leu Pro Leu Pro Cys Gly Gly Phe Arg Gly His 
        115                 120                 125             
Gly Leu Ala Arg Trp Ser Cys Pro Gly Phe Gln Phe Ala Arg Cys Pro 
    130                 135                 140                 
Gly Asp Leu Gly Ser Pro Asp Pro Ala Pro Pro Arg Thr Pro Leu Gly 
145                 150                 155                 160 
Ser Gly Trp Cys Lys His Thr Leu Ala Leu Cys Pro His Leu Ser Gly 
                165                 170                 175     
Pro Arg Leu Ser His Ser Ala Arg Ala Arg Gln Ala Val Ala Leu Gln 
            180                 185                 190         
Val Pro Val Leu Pro Ala Phe Pro Gln Val Gln Arg Pro Pro Arg Ser 
        195                 200                 205             
Leu Arg Val Gly Glu Ser Pro Phe Gln Arg Ser Arg Gly Gly Val Gly 
    210                 215                 220                 
Lys Ile Pro Thr Cys Arg Gly Arg Leu Gly His Pro Arg Cys Arg Cys 
225                 230                 235                 240 
Gly Leu Ala Gly Leu Glu Gly Thr Ala Ala Ala Asn 
                245                 250         

<210> 9
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.9

<400> 9
Leu Gly Ala Arg Thr Lys Ala Ala Val Ala Gln 
1               5                   10      

<210> 10
<211> 12
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.5 extended

<400> 10
Glu Asn Ser Arg Pro Arg Ile Pro Ile Ser Thr Phe 
1               5                   10          

<210> 11
<211> 31
<212> PRT
<213> Artificial Sequence


<220> 
<223> UH-axSpA-IgG.8 - short

<400> 11
Ile Pro Pro Gly Glu Leu Glu Ala Leu Glu Gly Ala Thr Ser Leu Glu 
1               5                   10                  15      
Ala Pro Leu Ser Glu Glu Glu Tyr Arg Ala Leu Leu Glu Glu Leu 
            20                  25                  30      

<210> 12
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> control peptide

<400> 12
Trp Thr Lys Thr Pro Asp Gly Asn Phe Gln Leu Gly Gly Thr Glu Pro 
1               5                   10                  15      



